Back
Grand Canyon Education Vs. Neurogene Industry Stock Comparison
Buy
65
LOPE
Grand Canyon Education
Last Price:
165.98
Seasonality Move:
-0.23%
Sell
5
NGNE
Neurogene
Last Price:
39.90
Seasonality Move:
50.43%
Buy
65
Grand Canyon Education (LOPE)
is a Buy
Is Grand Canyon Education a Buy, Sell or Hold?
- The current Grand Canyon Education [LOPE] share price is $168.34. The Score for LOPE is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- LOPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
LOPE Stock Price Chart
What is Grand Canyon Education's stock price today?
-
The Grand Canyon Education share price today is $168.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LOPE is experiencing selling pressure, which indicates risk of future bearish movement.
LOPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.34 | Buy |
| Relative Strength Index (14 RSI): | 78.9 | Buy |
| Chaikin Money Flow: | -120025 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (128.03 - 156.81) | Buy |
| Bollinger Bands (100): | (134.79 - 151.57) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.3 | Buy |
| Relative Strength Index (14 RSI): | 39.1 | Sell |
| Chaikin Money Flow: | -346626 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.29 - 61.53) | Sell |
| Bollinger Bands (100): | (34.11 - 50.51) | Sell |
LOPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 160.29 | Buy |
| 20-day SMA: | 144.67 | Buy |
| 50-day SMA: | 141.71 | Buy |
| 200-day SMA: | 139.43 | Buy |
| 8-day EMA: | 161.49 | Buy |
| 20-day EMA: | 150.57 | Buy |
| 50-day EMA: | 144.46 | Buy |
| 200-day EMA: | 138.6 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.39 | Sell |
| 20-day SMA: | 53.17 | Sell |
| 50-day SMA: | 46.66 | Sell |
| 200-day SMA: | 38.93 | Buy |
| 8-day EMA: | 54.03 | Sell |
| 20-day EMA: | 53.18 | Sell |
| 50-day EMA: | 48.36 | Sell |
| 200-day EMA: | 38.47 | Buy |
Grand Canyon Education Earnings Growth & LOPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $0.74 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Grand Canyon Education Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||